Findings revealed that DCLEX-TGF-β1si significantly boosted CD4+ T-cell proliferation, promoted Th1 cytokine secretion, and induced a robust tumor-specific cytotoxic T lymphocyte (CTL) response in vitro. Here, CD4 is linked to neoplasm.